Compare ALEMBIC LTD with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs WOCKHARDT - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD WOCKHARDT ALEMBIC LTD/
WOCKHARDT
 
P/E (TTM) x 72.9 -22.4 - View Chart
P/BV x 2.6 1.2 218.9% View Chart
Dividend Yield % 0.4 0.0 12,078.7%  

Financials

 ALEMBIC LTD   WOCKHARDT
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
WOCKHARDT
Mar-18
ALEMBIC LTD/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs721,012 7.1%   
Low Rs34532 6.4%   
Sales per share (Unadj.) Rs4.7355.9 1.3%  
Earnings per share (Unadj.) Rs6.1-60.3 -10.1%  
Cash flow per share (Unadj.) Rs6.2-46.8 -13.4%  
Dividends per share (Unadj.) Rs0.200.01 2,000.0%  
Dividend yield (eoy) %0.40 29,150.1%  
Book value per share (Unadj.) Rs40.7257.8 15.8%  
Shares outstanding (eoy) m267.03110.63 241.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.2 519.4%   
Avg P/E ratio x8.7-12.8 -67.8%  
P/CF ratio (eoy) x8.5-16.5 -51.4%  
Price / Book Value ratio x1.33.0 43.5%  
Dividend payout %3.30 -19,751.4%   
Avg Mkt Cap Rs m14,13985,379 16.6%   
No. of employees `000NA6.3 0.0%   
Total wages/salary Rs m2079,371 2.2%   
Avg. sales/employee Rs ThNM6,295.0-  
Avg. wages/employee Rs ThNM1,498.3-  
Avg. net profit/employee Rs ThNM-1,066.3-  
INCOME DATA
Net Sales Rs m1,25539,369 3.2%  
Other income Rs m3701,202 30.8%   
Total revenues Rs m1,62540,571 4.0%   
Gross profit Rs m11118 607.1%  
Depreciation Rs m381,495 2.5%   
Interest Rs m22,555 0.1%   
Profit before tax Rs m442-2,830 -15.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m24257 9.3%   
Profit after tax Rs m1,630-6,669 -24.4%  
Gross profit margin %8.90 19,041.6%  
Effective tax rate %5.4-9.1 -59.7%   
Net profit margin %129.8-16.9 -766.6%  
BALANCE SHEET DATA
Current assets Rs m1,86733,796 5.5%   
Current liabilities Rs m59126,917 2.2%   
Net working cap to sales %101.617.5 581.8%  
Current ratio x3.21.3 251.5%  
Inventory Days Days9479 118.8%  
Debtors Days Days7489 82.4%  
Net fixed assets Rs m1,79139,664 4.5%   
Share capital Rs m534553 96.5%   
"Free" reserves Rs m10,32427,968 36.9%   
Net worth Rs m10,85828,522 38.1%   
Long term debt Rs m4121,731 0.2%   
Total assets Rs m11,59181,620 14.2%  
Interest coverage x260.9-0.1 -242,638.6%   
Debt to equity ratio x00.8 0.5%  
Sales to assets ratio x0.10.5 22.5%   
Return on assets %14.1-5.0 -279.3%  
Return on equity %15.0-23.4 -64.2%  
Return on capital %15.2-7.7 -197.9%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m199,807 0.2%   
Fx outflow Rs m2641,789 14.8%   
Net fx Rs m-2448,019 -3.0%   
CASH FLOW
From Operations Rs m236684 34.5%  
From Investments Rs m-2246,302 -3.6%  
From Financial Activity Rs m-27-7,695 0.3%  
Net Cashflow Rs m-15-664 2.2%  

Share Holding

Indian Promoters % 64.0 74.5 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.3 8.7%  
FIIs % 9.7 7.7 126.0%  
ADR/GDR % 0.0 0.1 -  
Free float % 26.1 15.4 169.5%  
Shareholders   54,701 67,757 80.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  WYETH LTD  ABBOTT INDIA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Sep 19, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS